Hua Luo

Title: Hua Luo: Innovator in Biomedical Research

Introduction

Hua Luo is a prominent inventor based in Chongqing, China. He has made significant contributions to the field of biomedical research, particularly in the development of innovative therapeutic proteins. With a total of 2 patents, his work focuses on addressing critical health issues such as hyperuricemia, chronic gout, obesity, and diabetes.

Latest Patents

Hua Luo's latest patents include a PEGylated analogue protein of canine urate oxidase, which provides a preparation method and its use. This innovative protein can be utilized for the prevention and treatment of hyperuricemia and chronic gout. Additionally, he has developed a fusion protein that combines human fibroblast growth factor-21 and exendin-4. This fusion protein is part of a medicament composition aimed at treating or preventing obesity, diabetes, hyperglycemia, and hyperlipidemia.

Career Highlights

Throughout his career, Hua Luo has worked with Chongqing Fagen Biomedical Inc., where he has contributed to various research projects and innovations. His expertise in protein engineering and therapeutic applications has positioned him as a key figure in the biomedical field.

Collaborations

Hua Luo has collaborated with notable colleagues, including Kai Fan and Chun Zhang, who have supported his research endeavors and contributed to the development of his patented technologies.

Conclusion

Hua Luo's innovative work in the field of biomedical research highlights his commitment to advancing healthcare solutions. His patents reflect a dedication to addressing significant health challenges through scientific innovation.